Follow me on Twitter @madaznfootballr and Profit.ly www.profit.ly/users/madaz
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems like I found a cheat to this game, just hit Short and repeatedly click on Time Lapse. Works most of the time! LOL
SEFE bounces were very difficult to play. The fills were very difficult for many brokers.
Any issues trading the picks deep into the play? Like 1-2 weeks later, when they supposedly get on the "non-DTC" list?
Were you able to buy MDMC on ScottTrade? My friend has TD and wasn't able to because of "non-DTC related" issues.
This is on the official SpeedTrader website regarding non-DTC issues. Just wanna confirm that this hasn't been a big deal with peeps using SpeedTrader.
Trading non-DTC eligible securities will incur additional settlement fees including; a DTC PROC fee $75, DTC TRF fee $80 and shipping fee $40 (when necessary). There will also be a NYW fee and a TRF AGENT fee, which will vary and may be substantial.
ScottTrade I've heard horror stories about being stuck in non-DTC lockouts.
Any major issues like hidden fees or non-DTC lock outs?
Well it's that or dealing with stupid losses that aren't even my fault on Etrade due to no fills. I don't know of any other alternative brokers to use.
Really, I can't get filled on BDPS, TBX, 10 minutes to fill on Victory Mark, and now APS, its the last straw for me. That's pretty much all the promoters.
Yeah, I talked to him about that. But that's a rare case from what I heard. I mean right now Etrade is literally costing me thousands in both opportunity cost in potential gains AND realized losses because I can't get fills on sells.
Switching to SpeedTrader from Etrade after again slow fills have costed me another grand here. Any one have any serious cons about SpeedTrader that I should know before I do the switch?
Yup, I used to make a living off APS bounces, now I can't get filled when I'm trying to sell. Got in for a bounce at .35 with a small position tried to sell at .365 but no fill until .32! FFS...
Alright I'm pretty done with APS LOL. No fills on the first day, there's barely any good bounces to play except this last one. What's the point?
Awesome bro, just what I needed. I need to learn to print out these charts for future reference.
Cool Thanks man, appreciate it.
Does anyone have the intraday chart for PVTA for the first day of the pump? (7/9/12) Would greatly appreciate if you can post it here. Thanks!
Saw this and laughed my ass off.
Lame PRTN bounce this morning, just scalped 1 cent from .38 to .39...
I don't care how it happens frankly, I just want to make money. LOL
We'll see how they manage it with TBX and Victory Mark coming out with picks as well. Should be interesting to watch.
Well if it's truly an APS-style play, the "super dip", which typically occurs on day 3-4, is always gonna be a great bounce play opportunity.
I suppose, I'm going to go back after I get off work and look at the chart again with the corresponding volume. Right now I'm just going off of memory.
Yeah I see what you mean. Relative to the now low expectations of APS, it was a good close. My plan still remains, wait for a dip and get in. I'm not chasing squat.
There was massive wash trading on Friday. 21 Million the day before a pump. That was ridiculous.
True, but a gradual downtrend from the highs in Power Hour isn't the best close for any stock for that matter. It's hard to be bullish moving forwarding, seeing something like that. It desperately needed more demand in the .38-.40 levels, the sellers always overpowered the buyers there. We need to see that tomorrow for a run, imo.
The reaction from the banner being raised and the emails hitting wasn't what I expected however. A lot of people still dumped despite all that and the .40 break wasn't convincing either time.
I still think that is one ugly ass banner. Bet they made it on MS Paint in 5 minutes.
The best possible trade was getting in on the dip at .32-.33 and selling near the high at .40-.41.
I thought the premarket premium text / email thing to gap it up 50% was a low blow. I knew they were gonna do that after frontloading on Friday.
There was EOD selling pressure, not as bad as VLNX but it was there. I think there will be a pretty decent TMD tomorrow as many people will be selling the gap right away since no one still supposedly "trusts" APS.
Is the IP for Red Cappi APS email 50.28.16.50??
Screenshot please?
Can you post the screenshot?
I don't see a red cappi logo. But the emails are legit, checked the IPs.
It's the same comp they've been using in all their emails.
http://www.pennystocksexpert.com/images/nl/disclaimer.gif
Holding 75,000 shares of PRTN at .36 average.
Our next pick is: PRTN
Hi Everyone,
The long awaited pick is finally here. PRTN is our brand new pick of the (end of) summer, and we think this pick could be as good as our last medical-sector pick (which soared to over $2) from an alert at right around 30 cents.
Premium Members had the opportunity to come in at the market open earlier today and have already secured gains of about 50% (so for next time if you would like the same opportunity head over to PremiumStockReport dot com and sign up now).
In the interim you may still be able to benefit from a jump to over $2 which is a very respectable 600% + in gains from current levels.
PRTN announced this morning the completion of the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.
Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.
The drug indication, that Eaton Scientific named Tropine 3, is currently being prescribed and compounded by doctors in the Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment. The drug, homatropine, is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, and as a mydriatic in order to dilate the pupil. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic administration.
Homatropine has been prescribed continuously and safely in the United States for over 40 years."Every woman who has experienced hot flashes knows the devastating affects they have on themselves personally and on their loved ones.
Tropine 3 has been shown in individual cases to reduce the symptoms of hot flashes in terms of intensity, duration, and number of occurrences without the use of dangerous hormones which," said Michael Borkowski, CEO and President of Eaton Scientific Systems, Ltd. "We look forward to building market awareness and acceptance of Tropine 3 throughout the women's health care sector in hopes of improving the lives of the over 50 million women in America that would benefit from this proven safe and effective treatment for hot flashes."
The Company is currently assembling a senior management team and group of scientific advisors to assist in the ongoing development and clinical testing of Tropine 3. Clinical trials currently being contemplated will be performed to strict FDA standards to provide support to claims made in Eaton Scientific's patent filed under USPTO #60/719,756. Additional information regarding the near-term scheduling and commencement of planned Tropine 3 clinical trials will be made available in subsequent public statements.
You can visit the company's site at EatonScientific dot com
Our most successful picks in history have always been in the biotech/biomed sector and we really think that PRTN will be no exception to that rule.
Moreover September has also historically been the month where our picks perform better and we anticipate that PPRTN could be trading at MUCH higher than today come mid-end September.
We plan on covering this great company for many weeks to come as it seems like there's a lot of exciting things going on there, and we want to see the story develop more.
Important Pharmaceutical companies have always soared after FDA approval of their drugs and PRTN could do the same should clinical trials of Tropine 3 be successful and the FDA approves it.
In fact we saw a "pennystock" (on pinksheet) soar more than 2,000% after the FDA approved a drug it had worked on. The company was TTNP it went from 3 cents to more than $2 about 36 months ago. It soared in less than 30 days. and is still sitting at around $1 even today!
That's the type of enormous positive effect an FDA approval can have on a stock as it creates millionaires virtually overnight.
Watch PRTN very closely over the next few weeks as enormous things could be on the agenda!
Happy Trading!
Your FreePennyAlerts Editor.
Our next pick is: PRTN
Hi Everyone,
The long awaited pick is finally here. PRTN is our brand new pick of the (end of) summer, and we think this pick could be as good as our last medical-sector pick (which soared to over $2) from an alert at right around 30 cents.
Premium Members had the opportunity to come in at the market open earlier today and have already secured gains of about 50% (so for next time if you would like the same opportunity head over to PremiumStockReport dot com and sign up now).
In the interim you may still be able to benefit from a jump to over $2 which is a very respectable 600% + in gains from current levels.
PRTN announced this morning the completion of the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.
Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.
The drug indication, that Eaton Scientific named Tropine 3, is currently being prescribed and compounded by doctors in the Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment. The drug, homatropine, is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, and as a mydriatic in order to dilate the pupil. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic administration.
Homatropine has been prescribed continuously and safely in the United States for over 40 years."Every woman who has experienced hot flashes knows the devastating affects they have on themselves personally and on their loved ones.
Tropine 3 has been shown in individual cases to reduce the symptoms of hot flashes in terms of intensity, duration, and number of occurrences without the use of dangerous hormones which," said Michael Borkowski, CEO and President of Eaton Scientific Systems, Ltd. "We look forward to building market awareness and acceptance of Tropine 3 throughout the women's health care sector in hopes of improving the lives of the over 50 million women in America that would benefit from this proven safe and effective treatment for hot flashes."
The Company is currently assembling a senior management team and group of scientific advisors to assist in the ongoing development and clinical testing of Tropine 3. Clinical trials currently being contemplated will be performed to strict FDA standards to provide support to claims made in Eaton Scientific's patent filed under USPTO #60/719,756. Additional information regarding the near-term scheduling and commencement of planned Tropine 3 clinical trials will be made available in subsequent public statements.
You can visit the company's site at EatonScientific dot com
Our most successful picks in history have always been in the biotech/biomed sector and we really think that PRTN will be no exception to that rule.
Moreover September has also historically been the month where our picks perform better and we anticipate that PPRTN could be trading at MUCH higher than today come mid-end September.
We plan on covering this great company for many weeks to come as it seems like there's a lot of exciting things going on there, and we want to see the story develop more.
Important Pharmaceutical companies have always soared after FDA approval of their drugs and PRTN could do the same should clinical trials of Tropine 3 be successful and the FDA approves it.
In fact we saw a "pennystock" (on pinksheet) soar more than 2,000% after the FDA approved a drug it had worked on. The company was TTNP it went from 3 cents to more than $2 about 36 months ago. It soared in less than 30 days. and is still sitting at around $1 even today!
That's the type of enormous positive effect an FDA approval can have on a stock as it creates millionaires virtually overnight.
Watch PRTN very closely over the next few weeks as enormous things could be on the agenda!
Happy Trading!
Your FreePennyAlerts Editor.
Email are out!!!! holding 75,000 shares from .36
Then they show on Monday with the same pick as APS. Yup...LLOL